低温消融
乳腺癌
阿霉素
医学
癌症
光热治疗
材料科学
癌症研究
化疗
内科学
纳米技术
烧蚀
作者
Ping Ye,Haitao Yin,Xuelian Gu,Yuanyuan Ye,Qi Zhao,Zhaohua Chang,Baohui Han,Xiaoxiang Chen,Peifeng Liu
出处
期刊:Nanomedicine
[Future Medicine]
日期:2018-08-01
卷期号:13 (15): 1889-1903
被引量:5
标识
DOI:10.2217/nnm-2018-0168
摘要
Current cryoablation therapy easily induces a high tumor recurrence, it is therefore necessary to develop an effective method to enhance its antitumor efficacy.We solve the aforementioned problem by introducing doxorubicin (DOX) loading methoxy polyethylene glycol-polylactic-co-glycolic acid-poly-L-lysine-cyclic arginine-glycine-aspartic acid peptide nanoparticles (DOX nanoparticles) in the process of cryoablation.The combination of cryoablation and DOX nanoparticles greatly decreases the recurrence rate of breast cancer, which is owing to the specific targeting therapy of DOX nanoparticles for residuary breast cancer cells after cryoablation. Therefore, the survival time of MCF-7 breast cancer bearing mice significantly increases.The synergetic therapy of cryoablation and DOX nanoparticles is an effective therapy means for breast cancer. This strategy provides new means for treating breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI